|
|
|
| Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo |
| Xian-Shu Zhao, Peng-Long Song, Bei Sun, Hong-Chi Jiang and Tie-Fu Liu |
Harbin, China
Author Affiliations: Department of Gastroenterology (Zhao XS), Department of General Surgery (Sun B and Jiang HC), First Affiliated Hospital, Harbin Medical University, Harbin 150010, China; Department of Otolaryngology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China (Song PL); Department of Gastroenterology, Fourth Affiliated Hospital, Harbin Medical University, Harbin 150010, China (Liu TF)
Corresponding Author: Tie-Fu Liu, Professor, Department of Gastroenterology, Fourth Affiliated Hospital, Harbin Medical University, Harbin 150010, China (Tel: 86-451-86996128; Email: s_pl2008@hotmail.com) |
|
|
|
|
Abstract BACKGROUND: It has been pointed out that only low-dose arsenic trioxide (ATO) presents therapeutic benefits outweighing the toxic side effects. Low-dose ATO can effectively alleviate acute promyelocytic leukemia (APL). However, it is quite challenging in treating solid tumors. The purpose of this study was to investigate the effect of ATO at low concentrations on the metastatic potential of mouse hepatoma H22 cells and the anti-metastatic mechanism of ATO.
METHODS: The metastatic potential of H22 cells was evaluated by adhesion, migration and invasion assays after exposure to a low dose of ATO in vitro. The mouse lung metastatic model induced by injection of H22 cells via the tail vein was adopted for the evaluation of metastatic potential. Different proteins in the lysate of H22 cells exposed to ATO at different concentrations were investigated by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS). Finally, Western blotting analyses were made to detect the expression pattern of MMP-2 and nm23-M1 proteins.
RESULTS: Significant cell death started at ATO concentrations above 2 µmol/L. The growth and adhesion potential of H22 cells was inhibited in a time- and dose-dependent manner, and the migration and invasion potential of H22 cells was inhibited in a dose-dependent manner while ATO concentration was below 2 µmol/L. Mice injected with ATO at a dose of 0.5 mg/kg had fewer lung metastases. However, mice injected with ATO at a dose of 2 mg/kg or 4 mg/kg had a high mortality rate and more liver injuries. A total of 15 different protein peaks were identified between the lysate of H22 cells treated with ATO and controls. Two proteins that peaked at m/z 5302 and 17207 coincided with MMP-2 (fragment) and nm23-M1, respectively. Western blotting analyses demonstrated that MMP-2 and MMP-2 fragments were down-regulated and nm23-M1 was up-regulated in H22 cells treated with 2 µmol/L ATO for 48 hours.
CONCLUSIONS: ATO at a low dose inhibits the metastatic potential of mouse hepatoma H22 cells in vitro and in vivo, and involves down-regulation of MMP-2 and up-regulation of nm23-M1.
|
|
|
|
|
|
|
|
|
2009, Vol. 8 
